Efficacy of pharmacological interventions in COVID-19: A network meta-analysis
Covid-19의 약리학 적 개입의 효능 : 네트워크 메타 분석
Meta-Analysis
[키워드] 95% confidence interval
Administered
analysed
Clinical improvement
clinical recovery
Controlled trial
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
database
Dexamethasone
drug
Favipiravir
followed by
head
Head-to-head comparison
Hydroxychloroquine
increase
interferon
Intervention
investigator
Lopinavir
Lopinavir/ritonavir
lower mortality
lower risk
lower risk of mortality
MeSH term
moderate to severe
Mortality
Network meta-analysis
Occurrence
patients with moderate
pharmacological intervention
Quantitative analysis
Randomized controlled trial
reduce
reduced
Relative risk
Remdesivir
risk
Ritonavir
screened
Serious Adverse Event
Serious Adverse Events
severe COVID-19
significantly
Standard of care
Tocilizumab
was performed
[DOI] 10.1111/bcp.15338 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1111/bcp.15338 PMC 바로가기 [Article Type] Meta-Analysis